The Joint Corp. (NASDAQ:JYNT - Get Free Report) major shareholder Charles Jobson acquired 10,396 shares of Joint stock in a transaction on Wednesday, November 18th. The shares were bought at an average cost of $6.65 per share, for a total transaction of $69,133.40. Following the completion of the purchase, the insider directly owned 2,046,467 shares of the company's stock, valued at $13,609,005.55. The trade was a 0.51% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.
Joint Stock Performance
JYNT stock traded down $0.21 during midday trading on Thursday, reaching $6.43. 107,906 shares of the company traded hands, compared to its average volume of 80,904. The firm has a market capitalization of $88.10 million, a price-to-earnings ratio of 32.18 and a beta of 1.16. The Joint Corp. has a 52-week low of $6.42 and a 52-week high of $10.67. The business has a 50 day moving average of $7.41 and a 200-day moving average of $8.41.
Joint (NASDAQ:JYNT - Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. The firm had revenue of $13.55 million during the quarter, compared to analysts' expectations of $14.85 million. Joint had a return on equity of 22.11% and a net margin of 4.81%. Research analysts anticipate that The Joint Corp. will post 0.31 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. Wall Street Zen lowered shares of Joint from a "buy" rating to a "hold" rating in a research note on Saturday, November 14th. Weiss Ratings upgraded shares of Joint from a "sell (d)" rating to a "sell (d+)" rating in a research report on Wednesday, November 11th. Finally, B. Riley Financial reduced their target price on shares of Joint from $9.00 to $8.00 and set a "neutral" rating on the stock in a research note on Monday, November 9th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Joint has an average rating of "Reduce" and an average target price of $8.00.
Check Out Our Latest Stock Analysis on Joint
Hedge Funds Weigh In On Joint
Institutional investors have recently modified their holdings of the stock. R Squared Ltd boosted its holdings in shares of Joint by 40.3% in the third quarter. R Squared Ltd now owns 14,910 shares of the company's stock valued at $110,000 after purchasing an additional 4,284 shares during the period. Grandeur Peak Global Advisors LLC purchased a new position in Joint during the 2nd quarter worth $19,059,000. Susquehanna International Group LLP increased its holdings in Joint by 161.3% during the 2nd quarter. Susquehanna International Group LLP now owns 43,138 shares of the company's stock worth $379,000 after purchasing an additional 26,626 shares during the period. Squarepoint Ops LLC raised its position in Joint by 35.5% during the 2nd quarter. Squarepoint Ops LLC now owns 105,467 shares of the company's stock valued at $926,000 after purchasing an additional 27,633 shares in the last quarter. Finally, Verus Capital Partners LLC raised its position in Joint by 23.6% during the 1st quarter. Verus Capital Partners LLC now owns 130,705 shares of the company's stock valued at $1,157,000 after purchasing an additional 24,929 shares in the last quarter. 76.88% of the stock is owned by hedge funds and other institutional investors.
About Joint
(
Get Free Report)
The Joint Corp. operates and franchises The Joint Chiropractic, a network of clinics providing chiropractic care in the United States. Its clinics offer services such as spinal adjustments and other chiropractic treatments focused on musculoskeletal health and wellness. The company's business model emphasizes convenient access to care, with options that include walk-in visits and recurring membership plans. The Joint Corp. was established in 2010 and is headquartered in Scottsdale, Arizona.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.